CTNI-25. PHASE IB CLINICAL TRIAL OF CHRONIC CONVECTION-ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT GLIOBLASTOMA

OBJECTIVES: Convection-enhanced delivery (CED) provides pharmacokinetic advantages over systemic delivery for achieving cytotoxic drug levels into targeted regions of the brain. A major shortcoming of CED has been the need to limit treatment duration because of infection risks associated with extern...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Bruce, Jeffrey, Spinazzi, Eleonora, Lassman, Andrew, Iwamoto, Fabio, Welch, Mary, Banu, Matei, Argenziano, Michael, Upadhyayula, Pavan, Agar, Nathalie Y R, Humala, Nelson, Marie, Tamara, Pereira, Brianna, Sudhakar, Tejaswi, Mahajan, Aayushi, Neira, Justin, Lignelli-Dipple, Angela, Grinband, Jack, Sims, Peter, D’Amico, Randy, Canoll, Peter
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2020
Предметы:
Clinical Trials: Non-Immunologic
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650341/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.192
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы